KEVIN GONZALEZ: Open Payments
NPI 1790432110 · PALM SPRINGS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,601 in 63 payments from 13 companies in 2025. Trend: 2023 $1,155 · 2024 $1,662 · 2025 $1,601
Food & beverage: $1,502Education: $99
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 15 | $340 |
| GENZYME CORPORATION | 8 | $285 |
| Regeneron Healthcare Solutions, Inc. | 7 | $227 |
| ABBVIE INC. | 8 | $169 |
| LEO Pharma Inc. | 6 | $122 |
| Novartis Pharmaceuticals Corporation | 5 | $119 |
| UCB, Inc. | 3 | $109 |
| Incyte Corporation | 3 | $74 |
| PFIZER INC. | 3 | $65 |
| E.R. Squibb & Sons, L.L.C. | 2 | $31 |
Products named: DUPIXENT, Otezla, ADBRY, COSENTYX, Bimzelx, RINVOQ, OPZELURA, SKYRIZI.
Industry payments across CA — which companies pay providers there.
